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Abstract
Vitamin Dmay play a role in glucosemetabolism. A low vitamin D level has been associated with increased risk of diabetes
mellitus, but the association has not been confirmed in Asians. Our objective was to examine the association of serum
25-hydroxyvitamin D [25(OH)D] levels with insulin resistance and diabetes mellitus in Korean adults based on a large
population-based survey. Cross-sectional analyses were carried out on 5787 Korean adults (2453 men and 3334 women)
who were 20 y or older and participated in the Fourth Korea NHANES conducted in 2008. Diabetesmellitus was defined as
fasting plasma glucose$7 mmol/L or current use of oral hypoglycemic agents or insulin. Insulin resistance was estimated
by homeostatic model assessment for insulin resistance (HOMA-IR) and quantitative insulin sensitivity check index
(QUICKI). Compared to individuals with a sufficient serum 25(OH)D concentration $75 nmol/L, the OR (95% CI) for
diabetes mellitus were 1.73 (1.09–2.74), 1.30 (0.91–1.84), and 1.40 (0.99–1.98) for serum 25(OH)D concentrations ,25,
25 to ,50, and 50 to ,75 nmol/L, respectively, after multiple adjustments (P-trend , 0.0001). Furthermore, the serum
25(OH)D level was inversely associated with HOMA-IR (b =20.061; P = 0.001) and positively associatedwith QUICKI (b =
0.059; P = 0.001) in overweight or obese participants. In conclusion, a low serum vitamin D concentration is associated
with a high risk of diabetesmellitus in Korean adults and the concentration is inversely associated with insulin resistance in
those who are overweight or obese. J. Nutr. 141: 1524–1528, 2011.
Introduction
A traditional role of vitamin D is promoting calcium and
phosphate absorption in the intestine. It maintains adequate
concentrations of calcium and phosphate in the circulation and
enables normal mineralization of bone by providing these
minerals to bone-forming sites. Accordingly, vitamin D defi-
ciency is closely associated with metabolic bone diseases such as
rickets in children and osteomalacia in adults. Recently, the
nonskeletal actions of vitamin D are also drawing interest, as it
was discovered that most cells and tissues throughout the body
have the receptors for vitamin D and some of them also have the
enzyme 25-hydroxyvitamin D [25(OH)D]9-1a-hydroxylase,
which converts the primary form of vitamin D to an active
form (1–3).
One of the nonskeletal actions under active investigation is a
role of vitamin D in glucose metabolism (4). Animal and in vitro
studies have provided evidence that vitamin D may play a role in
glucose homeostasis through its effects on insulin secretion and
insulin sensitivity (5–10). Previous observational studies have
reported an inverse association between vitamin D status and
risk of diabetes mellitus (11–14), although some others could
not find such an association (15,16). The discrepancy may be
attributed to ethnic variation. Scragg et al. (11) reported that the
serum level of 25(OH)D was inversely associated with insulin
resistance and diabetes risk in non-Hispanic whites andMexican
Americans, but not in non-Hispanic blacks. In Arab Americans,
a low 25(OH)D level was associated with insulin resistance and
glucose intolerance only in men (13). In addition, serum 25(OH)D
was not associated with insulin resistance or b cell function in
Canadian Cree (16). However, little is known about whether the
association also exists in the Asian population.
Thus, we examined the association between the serum 25(OH)D
level and the prevalence of diabetes mellitus and insulin resis-
tance estimated by the homeostatic model assessment for insulin
resistance (HOMA-IR) and quantitative insulin sensitivity check
index (QUICKI) in Korean adults based on a large population-
based survey.
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Research Design and Methods
Study population. We conducted a cross-sectional study based
on the data acquired in the second year (2008) of the Fourth
Korea NHANES (KNHANES IV), which was conducted from
2007 to 2009. The KNHANES has been periodically conducted
since 1998 to assess the health and nutritional status of the
civilian, noninstitutionalized population of Korea by the Divi-
sion of Chronic Disease Surveillance under the Korea Centers for
Disease Control and Prevention. The survey consists of a health
interview, a nutrition survey, and a health examination. The
survey data were collected via household interviews and by
direct standardized physical examinations conducted in spe-
cially equipped mobile examination centers. The sampling frame
was based on the 2005 population and housing census of Korea.
A stratified, multistage probability sampling design was used for
the selection of household units. In the second year (2008) of the
KNHANES IV, there were 264,186 primary sampling units,
each of which contained ;60 households. Two hundred units
were randomly selected from the primary sampling units and
then 23 households from each unit were sampled using a
systemic sampling method. Finally, 12,528 individuals in 4600
households were sampled. Among them, 9308 participated in
health interviews and health examination surveys and 8641 in
nutrition surveys. Among adults who participated in the survey
between February and December 2008, 5902 participants (2502
men and 3400 women) aged 20 y or older were tested for fasting
glucose, TG, total and HDL cholesterol, insulin, and 25(OH)D
levels. Demographic, anthropometric, and behavioral charac-
teristics were also measured. After excluding those who had
missing values for analysis, a total of 5787 individuals (2453
men and 3334 women) were eligible for the present analysis. All
participants in this survey signed an informed consent form.
Diabetes mellitus was defined as fasting glucose $7 mmol/L or
current use of oral hypoglycemic agents or insulin for glucose
control. Insulin resistance was indirectly estimated by HOMA-
IR and QUICKI (17). The BMI cutoff values for overweight and
obesity were 23 and 25 kg/m2, respectively, as proposed by the
WHO Western Pacific Region (18). The institutional review
board of the Korea Centers for Disease Control and Prevention
approved the study protocol.
Laboratory methods. For measurements of serum 25(OH)D
levels, blood samples of the participants were collected during
the survey. Blood samples were properly processed, immediately
refrigerated, and transported in cold storage to the Central
Testing Institute in Seoul, Korea. Blood samples were analyzed
within 24 h after transportation. Serum 25(OH)D levels were
measured using a gamma counter (1470 Wizard, Perkin Elmer)
with a RIA (DiaSorin). Insulin levels were determined using a
gamma counter (1470 Wizard, Perkin Elmer) with an immunor-
adiometric assay (Biosource). The plasma glucose, total choles-
terol, TG, and HDL cholesterol levels were measured using
Hitachi Automatic Analyzer 7600 by enzymatic methods using
commercially available kits, Pureauto S GLU, Pureauto SCHO-N,
Pureauto S TG-N, and CHOLESTEST N HDL, respectively
(Daiichi Pure Chemicals).
Statistical analyses. Statistical analyses were carried out using
SAS V9.1 (SAS Institute). Demographic characteristics were
analyzed according to their serum 25(OH)D levels: ,25, 25 to
,50, 50 to ,75, and $75 nmol/L. For continuous variables,
ANCOVA was used to adjust for age and sex. The Cochran-
Armitage test for linear trend of serum 25(OH)D was used in
categorical data analysis. A general linear model using contrast
coefficients for linear trend analysis was used in continuous data
analysis. A multiple logistic regression model was used to
evaluate the OR and 95% CI of having diabetes for each group
of serum 25(OH)D levels compared to those with 25(OH)D
levels $75 nmol/L. A multiple linear regression model was used
to clarify the relationships between the response variables and
serum 25(OH)D. Natural logarithmic transformation was used
for skewed variables. Variables for adjustments included age
(continuous), sex (men or women), season (spring, summer, fall,
or winter), current smoking (yes or no), alcohol drinking (yes or
no), regular walking (yes or no), regular exercise (yes or no),
region (urban or rural), BMI (continuous), and waist circum-
ference (continuous). Alcohol drinking was indicated as “yes”
for participants who consumed at least one glass of alcohol every
month over the last 1 y. Regular walking was indicated as “yes”
for participants who walked for .30 min at a time and .5
times/wk regardless of indoor or outdoor walking. Regular
exercise was indicated as “yes” for participants who exercised
on a regular basis regardless of indoor or outdoor exercise (for
.30 min at a time and .5 times/wk in the case of moderate
exercise, such as swimming slowly, doubles tennis, volleyball,
badminton, table tennis, and carrying light objects; and for.20
min at a time and .3 times/wk in the case of vigorous exercise,
such as running, climbing, cycling fast, swimming fast, football,
basketball, jump rope, squash, singles tennis, and carrying heavy
objects). Region was categorized as urban and rural. Among the
16 administrative districts where this survey was conducted,
Seoul (the capital city of South Korea) and the surroundingmetro-
politan area (Gyeonggi) and 6 other metropolitan cities (Busan,
Daegu, Incheon, Gwangju, Daejeon, and Ulsan) were grouped
as urban areas. The remaining regions (Gangwon, Chungbuk,
Chungnam, Jeonbuk, Jeonnam, Gyeongbuk, Gyeongnam, and
Jeju) were grouped as rural areas. All statistical tests were
2-sided and the level of significance was 0.05. Values in the text
are mean 6 SD.
Results
The age of participants was 48.5 6 15.9 y in men and 49.1 6
16.5 y in women. BMI was 23.96 3.1 kg/m2 in men and 23.46
3.4 kg/m2 in women. Participants with ,25 nmol/L of serum
25(OH)D accounted for 7.9% of the study population, 25 to
,50 nmol/L for 48.2%, 50 to,75 nmol/L for 33.8%, and$75
nmol/L for 10.2%. The prevalence of diabetes mellitus in this
study was 9.3% in men and 8.3% in women. After adjusting for
age and sex, serum 25(OH)D level was inversely associated with
fasting glucose, fasting insulin, and HOMA-IR and positively
associated with QUICKI, HDL cholesterol, and total cholesterol
(Table 1).
Association between serum 25(OH)D levels and diabetes
mellitus. After adjusting for age, sex, and season (model 1), the
risk of having diabetes mellitus was higher in participants with
low serum 25(OH)D levels (,75 nmol/L) compared with those
with a sufficient serum 25(OH)D concentration $75 nmol/L
(P-trend , 0.0001) (Table 2). After further adjustment for
additional confounders (models 2 and 3), an increasing risk of
diabetes mellitus remained associated with decreasing serum
25(OH)D level (P-trend , 0.0001) (Table 2).
Association between serum 25(OH)D levels and insulin
resistance. The relationship between serum 25(OH)D level and
fasting glucose, fasting insulin, HOMA-IR, QUICKI, and lipid
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concentrations after excluding participants currently using oral
hypoglycemic agents or insulin are presented (Table 3). In multi-
variate regression analyses, including potential confounders,
serum 25(OH)D was inversely associated with fasting insulin
and HOMA-IR and positively associated with QUICKI, HDL
cholesterol, and total cholesterol (Table 3). There was a modi-
fying effect of BMI (,23 or $23 kg/m2) on the association
between serum 25(OH)D level and insulin resistance (P-
interaction = 0.022 and 0.038 for HOMA-IR and QUICKI,
respectively). In stratified analyses, serum 25(OH)D was in-
versely associated with HOMA-IR and positively associated
with QUICKI in overweight and obese participants with BMI
$23 kg/m2, but not in those with BMI,23 kg/m2, after multiple
adjustments (Table 3).
TABLE 1 Characteristics of study participants by serum 25-hydroxyvitamin D [25(OH)D] concentrations1
Serum 25(OH)D, nmol/L
,25 25 to ,50 50 to ,75 $75 P-trend
n 455 2790 1954 588 —
Age, y 47.7 6 0.9 46.5 6 0.3 50.5 6 0.4 55.3 6 0.6 ,0.00012
Men 111 (24.4) 995 (35.7) 994 (50.9) 353 (60.0) ,0.00013
Urban residents 349 (76.7) 1918 (68.7) 1105 (56.6) 261 (44.4) ,0.00013
Season of study participation
Summer 62 (13.6) 693 (24.8) 730 (37.4) 263 (44.7) ,0.00013
Fall 55 (12.1) 658 (23.6) 700 (35.8) 235 (40.0)
Winter 92 (20.2) 529 (19.0) 196 (10.0) 34 (5.8)
Spring 246 (54.1) 910 (32.6) 328 (16.8) 56 (9.5)
Current smoker
Men 58/111 (52.3) 477/995 (47.9) 407/994 (40.9) 158/353 (44.8) 0.01323
Women 27/344 (7.8) 119/1795 (6.6) 42/960 (4.4) 14/235 (6.0) 0.02803
Alcohol consumer4
Men 74/111 (66.7) 713/995 (71.7) 748/994 (75.3) 272/353 (77.1) 0.00523
Women 111/344 (32.3) 715/1795 (39.8) 388/960 (40.4) 75/235 (31.9) 0.743
Regular walking5 182 (40.0) 1285 (46.1) 986 (50.5) 337 (57.3) ,0.00013
Regular exercise6 80 (17.6) 679 (24.3) 602 (30.8) 223 (37.9) ,0.00013
Diabetes mellitus 50 (11.0) 219 (7.8) 190 (9.7) 47 (8.0) 0.963
BMI,7 kg/m2 23.3 6 0.2 23.6 6 0.1 23.7 6 0.1 23.1 6 0.1 0.682
Waist circumference,7 cm 80.4 6 0.4 81.5 6 0.2 82.2 6 0.2 80.7 6 0.4 0.372
Systolic blood pressure,7 mm Hg 115 6 1 116 6 0 115 6 0 115 6 1 0.772
Diastolic blood pressure,7 mm Hg 74 6 0 75 6 0 74 6 0 74 6 0 0.232
Fasting plasma glucose,7 mmol/L 5.50 6 0.06 5.49 6 0.02 5.43 6 0.03 5.30 6 0.05 0.00932
Fasting serum insulin,7 pmol/L 70.2 6 1.7 68.0 6 0.7 64.1 6 0.8 62.5 6 1.5 ,0.00012
HOMA-IR7 2.55 6 0.08 2.46 6 0.03 2.28 6 0.04 2.13 6 0.07 ,0.00012
QUICKI7 0.148 6 0 0.149 6 0 0.150 6 0 0.150 6 0 0.00022
Serum TG,7 mmol/L 1.45 6 0.06 1.58 6 0.02 1.49 6 0.03 1.39 6 0.05 0.272
Serum HDL cholesterol,7 mmol/L 1.31 6 0.01 1.34 6 0.01 1.35 6 0.01 1.38 6 0.01 0.00022
Serum total cholesterol,7 mmol/L 4.69 6 0.04 4.86 6 0.02 4.87 6 0.02 4.86 6 0.04 0.00282
1 Data are means 6 SE or n (%).
2 P-trend was derived from a general linear model using contrast coefficients for linear trend analysis.
3 P-trend was derived from the Cochran-Armitage trend test.
4 Alcohol drinking was indicated as ‘‘yes’’ for participants who consumed at least one glass of alcohol every month over the last 1 y.
5 Regular walking was indicated as ‘‘yes’’ for participants who walked for more than 30 min at a time and more than 5 times/wk.
6 Regular exercise was indicated as ‘‘yes’’ for participants who exercised on a regular basis (for more than 30 min at a time and more than 5 times/wk in the case of moderate
exercise and for more than 20 min at a time and more than 3 times/wk in the case of vigorous exercise).
7 ANCOVA was used to adjust for age and sex.
TABLE 2 Adjusted OR (95% CI) of Korean adults having diabetes by serum 25-hydroxyvitamin D [25(OH)D] concentrations
Serum 25(OH)D, nmol/L
,25 25 to ,50 50 to ,75 $75 P-trend1
Cases/participants, n/n (%) 50/455 (11.0) 219/2790 (7.8) 190/1954 (9.7) 47/588 (8.0)
Model 12 1.91 (1.23–2.97) 1.44 (1.03–2.03) 1.55 (1.10–2.18) 1.00 (ref) ,0.0001
Model 23 1.70 (1.09–2.67) 1.34 (0.95–1.90) 1.51 (1.07–2.13) 1.00 (ref) ,0.0001
Model 34 1.73 (1.09–2.74) 1.30 (0.91–1.84) 1.40 (0.99–1.98) 1.00 (ref) ,0.0001
1 The P-trend estimate is the asymptotic Cochran-Armitage trend test in logistic regression. The serum 25(OH)D level was treated as a continuous variable.
2 Model 1: adjusted for age (continuous), sex (men or women), and season (spring, summer, fall, or winter).
3 Model 2: adjusted as in model 1 plus current smoking (yes or no), alcohol drinking (yes or no), regular walking (yes or no), regular exercise (yes or no), and region (urban or rural).
4 Model 3: adjusted as in model 2 plus BMI (continuous) and waist circumference (continuous).
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Discussion
In this study, we demonstrated that low vitamin D status was
associated with an increased risk of diabetes mellitus in Korean
adults. Although several observational studies have reported an
inverse association between vitamin D level and the risk of
diabetes mellitus (11–14), few studies reported such an associ-
ation in the Asian population. Regarding the association
between vitamin D level and the risk of metabolic syndrome in
Asians, Lu et al. (19) reported that a low serum 25(OH)D level is
significantly associated with a high risk of metabolic syndrome
in Chinese people between 50 and 70 y of age. They also noted
that serum 25(OH)D level was inversely associated with insulin
resistance in overweight and obese Chinese people (BMI $24
kg/m2), but not in their normal-weight counterparts, which is
consistent with our results. Although there is no clear explana-
tion for this discrepancy in the associations depending on BMI in
the Asian population, vitamin Dmay play a more important role
in glucose homeostasis in overweight and obese individuals who
already have some degree of insulin resistance.
Potential mechanisms for the effects of vitamin D on glucose
homeostasis have been suggested based on the findings from
animal and in vitro studies (4–10). It appears that vitamin Dmay
play a role in both insulin secretion and insulin resistance. It was
shown that vitamin D receptors are present on pancreatic b-cells
(5) and skeletal muscle (6), and the activating enzyme, 25(OH)
D-1a-hydroxylase, is expressed in pancreatic b-cells (7). Vita-
min D may directly induce insulin secretion by binding to
vitamin D receptors on b-cells, or it may indirectly affect b-cell
function by regulating extracellular calcium level and calcium
flux through b-cells (4). Vitamin D stimulates the expression of
insulin receptor and enhances insulin responsiveness for glucose
transport in cells (8). It also indirectly affects insulin sensitivity
in tissues such as skeletal muscle and fat by regulating
extracellular calcium level and ensuring adequate intracellular
cytosolic calcium pool, which is essential for insulin-mediated
intracellular processes (4).
There is still no definite consensus on optimal serum levels of
25(OH)D. Estimates of the optimal serum 25(OH)D level,
which has been defined as the concentration that maximally
suppresses serum parathyroid hormone, widely vary from 20 to
110 nmol/L (20). Bischoff-Ferrari et al. (20) reviewed evidence
from studies that evaluated thresholds for serum 25(OH)D
levels in relation to skeletal and nonskeletal outcomes, including
bone mineral density, fractures, dental health, risk of falls, lower
extremity function, and colorectal cancer. For all endpoints, they
found that the most advantageous serum levels of 25(OH)D
begin at 75 nmol/L and the optimal level ranged between 90 and
100 nmol/L. Based on these findings, they recommended that the
vitamin D intake for adults should be$1000 IU/d (to convert IU
of vitamin D to mg, divide by 40,000). However, a recent report
by the Institute of Medicine suggested that a serum 25(OH)D
level of 50 nmol/L is sufficient to ensure bone health and set the
recommended dietary allowances of vitamin D at 600 IU/d for
everyone aged 1–70 y and 800 IU/d for adults age 71 y and older
(21), as it caused a controversy over the optimal serum 25(OH)D
level and adequate vitamin D intake. Meanwhile, an optimal
vitamin D level should also be determined based on health
outcomes other than bone health, such as diabetes mellitus and
cardiovascular diseases, considering various potential effects of
vitamin D on health. In the present study, the risk of having
diabetes mellitus was higher in participants with low serum
25(OH)D levels compared with those with a sufficient serum
25(OH)D concentration $75 nmol/L. There should be more
studies to estimate optimal serum 25(OH)D concentrations in
various health outcomes.
As we previously reported (22), vitamin D insufficiency,
which is defined as a serum 25(OH)D level ,50 nmol/L, is very
common in Koreans (47.3% of men and 64.5% of women).
With a serum 25(OH)D level of 75 nmol/L as the threshold, the
prevalence of vitamin D insufficiency rises to 86.8% in men and
93.3% in women. Meanwhile, diabetes mellitus and impaired
fasting glucose have become very common conditions in Korea.
In 2005, the prevalence of diabetes mellitus and impaired fasting
glucose was estimated at 9.1 and 17.4%, respectively (23).
Although the high prevalence of such conditions are mainly
attributed to increasing obesity and other environmental factors
TABLE 3 Adjusted regression coefficients of 25-hydroxyvitamin D [25(OH)D] with fasting glucose, insulin, HOMA-IR, QUICK, and lipid
concentrations in Korean adults
Model 11 Model 22 Model 33
Standardized b P Standardized b P Standardized b P
All (n = 5462)4
Fasting glucose 20.002 0.88 0.001 0.97 20.002 0.90
Fasting insulin5 20.066 ,0.0001 20.044 0.002 20.048 0.0001
HOMA-IR5 20.057 ,0.0001 20.037 0.012 20.041 0.002
QUICKI5 0.055 0.0001 0.034 0.020 0.038 0.003
TG5 20.026 0.05 20.019 0.17 20.022 0.09
HDL cholesterol 0.041 0.003 0.031 0.026 0.033 0.014
Total cholesterol 0.028 0.041 0.036 0.012 0.034 0.015
BMI ,23 (n = 2494)4
HOMA-IR5 20.032 0.14 20.009 0.68 20.013 0.53
QUICKI5 0.029 0.17 0.006 0.77 0.011 0.61
BMI $23 (n = 2968)4
HOMA-IR5 20.086 ,0.0001 20.063 0.001 20.061 0.001
QUICKI5 0.084 ,0.0001 0.061 0.002 0.059 0.001
1 Model 1: adjusted for age (continuous), sex (men or women), and season (spring, summer, fall, or winter).
2 Model 2: adjusted as in model 1 plus current smoking (yes or no), alcohol drinking (yes or no), regular walking (yes or no), regular exercise (yes or no), and region (urban or rural).
3 Model 3: adjusted as in model 2 plus BMI (continuous) and waist circumference (continuous).
4 Excluding those currently using oral hypoglycemic agents or insulin.
5 Log transformations.
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such as unhealthy dietary habits and inactivity, vitamin D
insufficiency may also partly explain this phenomenon in Korea,
considering the possible role of vitamin D in glucose homeostasis.
The major strength of our study is that we included a large
number of Koreans aged 20 y or older from all administrative
areas of South Korea. To our knowledge, this is the first study
that demonstrated the association between a low serum level of
25(OH)D and a high risk of having diabetes mellitus in the Asian
population. The present study has some limitations. First,
because it is a cross-sectional observation study, the association
found in this study is not proof of a causal relationship and
might be confounded bymany unmeasured and unaccounted-for
variables even after multiple adjustments. Previously, only a few
intervention studies have shown that vitamin D supplementation
can improve insulin secretion or sensitivity (24–26). We suggest
a well-designed, randomized, controlled trial with a primary
endpoint of prevention of diabetes mellitus is also necessary.
Second, insulin resistance was estimated by only indirect methods
such as HOMA-IR and QUICKI. Third, diabetes mellitus was
defined as fasting glucose $7 mmol/L or current use of oral
hypoglycemic agents or insulin. Because measurement of the
hemoglobin A1c level or an oral glucose tolerance test was not
used in this study, a considerable number of diabetics might have
been missed in the analyses.
In conclusion, we found that a low serum 25(OH)D con-
centration is significantly associated with a high risk of diabetes
mellitus in Korean adults and that the serum 25(OH)D level is
inversely associated with insulin resistance in overweight and
obese Korean adults. These results suggest that maintaining a
sufficient level of vitamin D might be important for glucose
homeostasis in Korean adults, especially in those with over-
weight and obesity. Further investigation into whether vitamin
D supplementation may prevent the development of insulin
resistance or diabetes mellitus in Koreans is necessary.
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